Para pesquisar informação científica, deverá especificar pelo menos dois termos de pesquisa
Search Medical Information
May 17 - 20, 2025
HTML
Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial
PDF
Dapagliflozin for HFrEF: early experience of treatment adherence and impact on patient-reported outcomes in EVOLUTION HF, a multinational, observational study
pdf
Real-world burden of heart failure with reduced ejection fraction and dapagliflozin use at 2 years after approval in 9 countries from Central Eastern Europe and Baltic Area: EVOLUTION-HF CEE-BA study
SOdium-Glucose cotransporter 2 inhibitor with and without an ALDosterone AntagonIst for heart failure with Preserved Ejection Fraction: the SOGALDI-PEF trial
Cardiorenal pathways and characteristics of patients with coexisting heart failure and chronic kidney disease (The CaRe Study)
Treatment patterns and clinical outcomes following diagnosis in patients with ATTR amyloidosis – results from the OverTTuRe study
Early clinical manifestations and time-to-diagnosis in patients with ATTR amyloidosis with mixed phenotype – results from the OverTTuRe study
Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimisation in heart failure with reduced ejection fraction: the REALIZE-K open-label run-In phase
Não encontra o que procura?
Contacte-nos
Encontre um Medical Healthcare Partner
Submeter uma questão